MMP3

matrix metallopeptidase 3, the group of M10 matrix metallopeptidases

Basic information

Region (hg38): 11:102835801-102843609

Previous symbols: [ "STMY1", "STMY" ]

Links

ENSG00000149968NCBI:4314OMIM:185250HGNC:7173Uniprot:P08254AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MMP3 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MMP3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
8
clinvar
12
missense
28
clinvar
3
clinvar
1
clinvar
32
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
2
2
non coding
1
clinvar
14
clinvar
15
Total 0 0 28 8 24

Variants in MMP3

This is a list of pathogenic ClinVar variants found in the MMP3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-102836175-G-C not specified Uncertain significance (Apr 13, 2022)2284267
11-102836574-G-A Benign (Nov 12, 2018)1263820
11-102837183-A-G Benign (Nov 12, 2018)1286978
11-102837312-A-G not specified Uncertain significance (Jun 24, 2022)2295819
11-102837326-T-C Likely benign (May 17, 2018)735165
11-102837331-C-A not specified Uncertain significance (Jan 07, 2022)2270702
11-102837357-T-C not specified Uncertain significance (Feb 26, 2024)3167343
11-102838611-G-A not specified Uncertain significance (Oct 03, 2022)2389139
11-102838615-C-T not specified Uncertain significance (Jul 27, 2022)3167272
11-102838649-G-A Benign (Jul 15, 2018)781045
11-102838654-T-A not specified Uncertain significance (Jul 19, 2022)2302088
11-102838694-A-G not specified Benign (Nov 12, 2018)403094
11-102838730-CAG-C Benign (Nov 12, 2018)1246283
11-102838791-T-A Benign (Nov 12, 2018)1274196
11-102839154-G-T not specified Uncertain significance (Apr 12, 2024)3295344
11-102839190-G-T not specified Uncertain significance (May 24, 2023)2551316
11-102839209-G-A not specified Uncertain significance (May 09, 2023)2545962
11-102839216-C-A not specified Uncertain significance (Apr 07, 2022)2387584
11-102839352-G-A Benign (Jun 21, 2021)1223368
11-102839976-T-A Benign (Nov 12, 2018)1286348
11-102840185-C-A Benign (Jul 23, 2018)781046
11-102840213-G-A not specified Uncertain significance (Oct 20, 2021)2219919
11-102840228-G-T not specified Uncertain significance (Feb 13, 2024)3167899
11-102840234-G-A not specified Uncertain significance (Jan 10, 2023)2460486
11-102840251-T-C MMP3-related disorder Benign (Dec 31, 2019)770980

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MMP3protein_codingprotein_codingENST00000299855 108003
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
5.74e-150.014612559101551257460.000617
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.6442852561.110.00001283136
Missense in Polyphen9480.1771.17241004
Synonymous-1.3811496.81.180.00000515920
Loss of Function0.03412222.20.9920.00000112275

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.002210.00220
Ashkenazi Jewish0.0002980.000298
East Asian0.0009260.000925
Finnish0.00004620.0000462
European (Non-Finnish)0.0003640.000360
Middle Eastern0.0009260.000925
South Asian0.001150.00114
Other0.0009830.000978

dbNSFP

Source: dbNSFP

Function
FUNCTION: Can degrade fibronectin, laminin, gelatins of type I, III, IV, and V; collagens III, IV, X, and IX, and cartilage proteoglycans. Activates procollagenase.;
Disease
DISEASE: Coronary heart disease 6 (CHDS6) [MIM:614466]: A multifactorial disease characterized by an imbalance between myocardial functional requirements and the capacity of the coronary vessels to supply sufficient blood flow. Decreased capacity of the coronary vessels is often associated with thickening and loss of elasticity of the coronary arteries. {ECO:0000269|PubMed:12477941, ECO:0000269|PubMed:8662692}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. A polymorphism in the MMP3 promoter region is associated with the risk of coronary heart disease and myocardial infarction, due to lower MMP3 proteolytic activity and higher extracellular matrix deposition in atherosclerotic lesions.;
Pathway
TNF signaling pathway - Homo sapiens (human);Prostate cancer - Homo sapiens (human);IL-17 signaling pathway - Homo sapiens (human);Transcriptional misregulation in cancer - Homo sapiens (human);Rheumatoid arthritis - Homo sapiens (human);Matrix Metalloproteinases;Oncostatin M Signaling Pathway;Photodynamic therapy-induced NF-kB survival signaling;Protein alkylation leading to liver fibrosis;Interleukin-4 and 13 signaling;Signaling by GPCR;Assembly of collagen fibrils and other multimeric structures;Signal Transduction;Collagen degradation;Collagen formation;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Degradation of the extracellular matrix;EGFR Transactivation by Gastrin;Posttranslational regulation of adherens junction stability and dissassembly;Gastrin-CREB signalling pathway via PKC and MAPK;G alpha (q) signalling events;GPCR downstream signalling;p75(NTR)-mediated signaling;Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling (Consensus)

Recessive Scores

pRec
0.866

Intolerance Scores

loftool
0.898
rvis_EVS
-0.66
rvis_percentile_EVS
15.91

Haploinsufficiency Scores

pHI
0.127
hipred
N
hipred_score
0.182
ghis
0.416

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.589

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Mmp3
Phenotype
homeostasis/metabolism phenotype; immune system phenotype; hematopoietic system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype;

Gene ontology

Biological process
proteolysis;negative regulation of hydrogen peroxide metabolic process;cytokine-mediated signaling pathway;extracellular matrix disassembly;extracellular matrix organization;collagen catabolic process;positive regulation of protein oligomerization;cellular response to nitric oxide;regulation of neuroinflammatory response;positive regulation of oxidative stress-induced cell death
Cellular component
extracellular region;extracellular space;extracellular matrix
Molecular function
endopeptidase activity;metalloendopeptidase activity;serine-type endopeptidase activity;protein binding;metallopeptidase activity;zinc ion binding